Skip to main content
Clinical Trials/NL-OMON55323
NL-OMON55323
Recruiting
Not Applicable

Improving the outcome of chronic subdural hematoma by embolization of the middle meningeal artery (ELIMINATE). - Embolization in chronic subdural hematoma

Academisch Medisch Centrum0 sites170 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
170

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • \- Has a head\-CT or MRI confirmed diagnosis of cSDH
  • \- Primary surgical treatment based on clinical symptoms (progressive
  • neurological deficits)

Exclusion Criteria

  • \- Significant contraindication to angiography (eg. allergy for contrast,
  • inability to lay still);
  • \- Structural causes for subdural haemorrhage, e.g. arachnoid cysts, cortical
  • vascular malformations and a history of cranial surgery \<1year
  • \- Inability to obtain informed consent from the patient or legal representative
  • (when the patient has a depressed level of consciousness), including language
  • \- Monocular blindness contralateral to hematoma;
  • \- Surgical treatment with craniotomy

Investigators

Similar Trials